| abstract |
A composition for treating, reducing, ameliorating, or alleviating a back-of-the- eye condition or disorder that has an etiology in inflammation comprises a dissociated glucocorticoid receptor agonist ('DIGRA'). The compositions also can include other anti-inflamatory agents, anti-angiogenic agents, or combinations thereof. The composition can be formulated for topical application, injection, or implantation. The composition can be administered alone or in combination with another procedure chosen to enhance the outcome of the treatment. |